<span style="display: block; margin-top: 60px;"> Admelog<sup>®<span style="color: black;">▼</span></sup><span style="font-size: 0.6em; display: block; margin: 5px 0;">(Insulin lispro 100 units/mL)</span></span>
The first rapid acting insulin biosimilar of Humalog approved in the UK1
Admelog is the new name for Insulin lispro Sanofi which is available to prescribe in England, Scotland and Wales.
25% lower NHS list price vs. Humalog cartridges and pre-filled pens and 15% lower NHS list price vs. Humalog vials2
1:1 initial unit dosing* – available in the SoloSTAR® pen, cartridges and vials1
*Changes in strength, brand, type, species and/or method of manufacture may result in the need for a change in dosage. Transferring to a different insulin should be done under strict medical supervision
Similar PK/PD profile (T1DM)3, efficacy, safety and tolerability profiles (T1DM and T2DM)4-5
Diabetes Stories
Learn from other payors, consultants and diabetes specialist nurses how they adopted a rapid acting insulin biosimilar in their region.
Dr Duncan Browne
Consultant Endocrinologist and Researcher Royal Cornwall Hospitals NHS Foundation Trust
Amanda Veall
Diabetes Specialist Nurse Cornwall Partnership NHS Foundation Trust
Marcus Jones
Formulary Pharmacist Gloucestershire Hospitals NHS Foundation Trust
Find useful resources such as formulary FAQ, leave pieces and videos for payors and healthcare professionals to support a positive rapid acting insulin biosimilar adoption
Abbreviations:
DSN, diabetes specialist nurse; EU, European Union, NHS, National Health Service; PD, pharmacodynamic; PK, pharmacokinetic; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus; UK, United Kingdom.
References:
- Admelog SmPC October 2021
- The NHS Dictionary of Medicines and Devices Admelog: solution for injection. Available at: https://services.nhsbsa.nhs.uk/dmd-browser/search/results?ampName=admelog&searchType=AMP&showInvalidItems=false&size=50 Last accessed: October 2021
- Kapitza C, et al. Diabetes Obes Metab. 2017;19(5):622–7.
- Garg SK, et al. Diabetes Technol Ther. 2017;19(9):516–26
- Derwahl K, et al. Diabetes Technol Ther. 2018;20(1):1–10.